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Abstract. 
 
Ezrin/radixin/moesin (ERM) proteins have 
been thought to play a central role in the organization 
of cortical actin-based cytoskeletons including microvil-
lar formation through cross-linking actin ﬁlaments and 
integral membrane proteins such as CD43, CD44, and 
ICAM-2. To examine the functions of these ERM-bind-
ing membrane proteins (ERMBMPs) in cortical
morphogenesis, we overexpressed ERMBMPs (the
extracellular domain of E-cadherin fused with the 
transmembrane/cytoplasmic domain of CD43, CD44, 
or ICAM-2) in various cultured cells. In cultured ﬁbro-
blasts such as L and CV-1 cells, their overexpression 
signiﬁcantly induced microvillar elongation, recruiting 
ERM proteins and actin ﬁlaments. When the ERM-
binding domains were truncated from these molecules, 
their ability to induce microvillar elongation became 
undetectable. In contrast, in cultured epithelial cells 
such as MTD-1A and A431 cells, the overexpression of 
ERMBMPs did not elongate microvilli. However, in 
the presence of EGF, overexpression of ERMBMPs in-
duced remarkable microvillar elongation in A431 cells. 
These results indicated that ERMBMPs function as or-
ganizing centers for cortical morphogenesis by organiz-
ing microvilli in collaboration with activated ERM
proteins. Furthermore, immunodetection with a phos-
phorylated ERM-speciﬁc antibody and site-directed 
mutagenesis suggested that ERM proteins phosphory-
lated at their COOH-terminal threonine residue repre-
sent activated ERM proteins.
Key words: ezrin • radixin • moesin • ERM • mi-
crovilli
 
P
 
LASMA
 
 membranes can be classified into two do-
mains: cell adhesion and free surface domains. In
the former domain, their outer surface interacts
with extracellular matrix or plasma membranes of adja-
cent cells, while in the latter it is covered with fluid compo-
nents. The actin cytoskeleton is essential for the morpho-
genesis of both domains. In the cell adhesion domain,
especially in integrin-based focal adhesions and cadherin-
based cell-to-cell adherens junctions, how actin filaments
are involved in the morphogenesis of these membrane do-
mains has been examined in detail (Geiger, 1983; Gum-
biner, 1996). The formation of the cell adhesion domain is
initiated by binding of specific ligands to cell adhesion
molecules, integrins, or cadherins. These activated adhe-
sion molecules are thought to recruit specific cytoplasmic
proteins such as talin, vinculin, paxillin, 
 
a
 
-actinin, tensin,
ZO-1, and various signaling molecules, which may nucle-
ate and organize actin-based cytoskeletons underlying the
cell adhesion domain (Yonemura et al., 1995; Burridge et al.,
1997; Yamada and Geiger, 1997).
The free surface domain is characterized by various
types of cellular protrusions such as microvilli, filopodia,
and lamellipodia which contain abundant actin filaments
(Bretscher, 1991; Condeelis, 1993; Hitt and Luna, 1994;
Mooseker and Cheney, 1995; Mitchison and Cramer,
1996). These cellular protrusions are known to be formed
and destroyed dynamically in response to various signals
(Chinkers et al., 1979; Stossel, 1993; Greenberg, 1995;
Forte and Yao, 1996; Hallett, 1997; Tapon and Hall, 1997).
Compared to focal adhesions and cell-to-cell adherens
junctions, however, our knowledge regarding the molecu-
lar sequences responsible for their morphogenesis is still
limited. Experimentally, the formation of cellular protru-
sions was induced by overexpressing several cytoskeletal
proteins. Overexpression of villin, an actin-bundling pro-
tein identified in intestinal microvilli, resulted in marked
elongation of microvilli in CV-1 cells (Friederich et al.,
1989). Also, when T-plastin, another actin-bundling pro-
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tein, was overexpressed, microvilli were elongated in
LLC-PK1 cells (Arpin et al., 1994b). Pleckstrin, which in-
teracts with lipids, promoted the formation of membrane
projections in Cos-1 cells (Ma et al., 1997). However, there
have been no reports indicating the existence of integral
membrane proteins which function as organizing centers
for the morphogenesis of cellular protrusions as integrins
do in the formation of focal adhesions.
Ezrin/radixin/moesin (ERM)
 
1
 
 proteins are localized
mainly just beneath the plasma membranes of cellular pro-
trusions such as microvilli, and are thought to function as
cross-linkers between plasma membranes and actin fila-
ments (Arpin et al., 1994a; Bretscher et al., 1997; Tsukita
et al., 1997a,b). ERM proteins bind to actin filaments
mainly at their COOH-terminal domain (Algrain et al.,
1993; Turunen et al., 1994; Henry et al., 1995; Martin et al.,
1995; Pestonjamasp et al., 1995), and at their NH
 
2
 
-terminal
half they associate with the cytoplasmic domains of several
integral membrane proteins such as CD43, CD44, and
ICAM-1, -2, and -3 (Algrain et al., 1993; Yonemura et al.,
1993; Tsukita et al., 1994; Henry et al., 1995; Helander et al.,
1996; Hirao et al., 1996; Serrador et al., 1997; Heiska et
al., 1998). Recently, a positively charged amino acid clus-
ter in the juxta-membrane portion was identified as an
ERM protein-binding region in CD43, CD44, and ICAM-2
(Legg and Isacke, 1998; Yonemura et al., 1998). As an al-
ternative to the ERM protein-plasma membrane inter-
action, ezrin was reported to indirectly bind to Na
 
1
 
/H
 
1
 
exchanger 3 (NHE3) via a cytoplasmic phosphoprotein
called EBP50 or NHE-RF (Reczek et al., 1997; Yun et al.,
1997; Murthy et al., 1998).
Soluble ERM proteins in the cytoplasm are dormant in
terms of their cross-linking activity through mutual in-
tramolecular and/or intermolecular association of their
NH
 
2
 
- and COOH-terminal halves. Some cellular signals
are thought to activate these dormant ERM proteins by
exposing their halves to allow them to interact with inte-
gral membrane proteins and actin filaments (Berryman et al.,
1995; Bretscher et al., 1995; Gary and Bretscher, 1995;
Hirao et al., 1996; Matsui et al., 1998). These activated
ERM proteins have been shown to be directly involved in
the morphogenesis of the free surface domain of plasma
membranes, especially in the organization of microvilli.
For example, overexpression of the COOH-terminal half
of ezrin or radixin induced abnormally long cellular pro-
trusions (Henry et al., 1995; Martin et al., 1995), and over-
expression of the NH
 
2
 
-terminal half of ezrin prevented
formation of microvilli (Crepaldi et al., 1997). Further-
more, the suppression of ERM protein expression with an-
tisense oligonucleotides in cultured cells resulted in com-
plete disappearance of microvilli (Takeuchi et al., 1994).
At the initial stage of anoxic injury and the apoptotic pro-
cess, most microvilli disappear from the cell surface, and in
both cases ERM proteins are translocated from microvilli
to the cytoplasm with their concomitant dephosphoryla-
tion (Chen et al., 1995; Kondo et al., 1997).
Considering that in focal adhesions activated integrins
recruit talin, vinculin, paxillin, etc., to organize the un-
derlying actin-based cytoskeleton, the question has natu-
rally arisen whether ERM-binding membrane proteins
(ERMBMPs) such as CD44, CD43, and ICAM-2 function
as organizers for the recruitment of ERM proteins and ac-
tin filaments to organize microvilli. In the present study,
we overexpressed ERMBMPs (the extracellular domain
of E-cadherin fused with the transmembrane/cytoplasmic
domain of CD43, CD44, or ICAM-2) in several cell lines,
and found that these proteins induce formation and elon-
gation of microvilli in collaboration with activated ERM
proteins. This study has led to a better understanding of
the molecular sequences of the morphogenesis of the free
surface domain of plasma membranes.
 
Materials and Methods
 
Cells and Antibodies
 
CV-1 monkey kidney cells (Jensen et al., 1964) and A431 human epider-
moid cells (Giard et al., 1973) were obtained from Health Science Re-
search Resources Bank. Mouse fibroblastic L cells (Earle, 1943) and
MTD-1A epithelial cells (Enami et al., 1984) were provided by M. Takei-
chi (Kyoto University, Kyoto, Japan). These cells were cultured in DME
supplemented with 10% FCS.
Mouse anti-ERM mAb (CR22) with higher affinity to moesin than to
ezrin/radixin (Sato et al., 1991), rat anti-ezrin mAb (M11), rat anti-radixin
mAb (R2-1) and rat anti-moesin mAb (M22) (Takeuchi et al., 1994), rat
anti–COOH-terminal phosphorylated ERM (CPERM) mAb (297S) spe-
cific for phosphorylated ERM proteins at T567, T564, or T558 for ezrin,
radixin, or moesin, respectively (Matsui et al., 1998), and rabbit anti-ERM
polyclonal antibodies (pAbs) (TK88 and TK89) (Kondo et al., 1997) were
used. TK88 was raised in a rabbit against synthesized peptides corre-
sponding to the mouse ERM proteins’ common sequence (293–302) and
detected all ERM proteins. Rabbit anti–E-cadherin pAb (Nagafuchi et al.,
1987) and rat anti–E-cadherin mAb (ECCD-2; Shirayoshi et al., 1986)
were provided by M. Takeichi. IM7.8.1 is a rat anti–mouse CD44 mAb
(Trowbridge et al., 1982). Mouse anti–phosphotyrosine mAb (clone
4G10) and mouse anti-vesicular stomatitis virus glycoprotein G (VSVG)
mAb (clone P5D4) were purchased from Upstate Biotechnology Inc. and
Sigma Chemical Co., respectively.
 
Mammalian Expression Vectors and Transfection
 
Some vectors used in this study were described previously (Yonemura et al.,
1993, 1998). E-43, E-44, or E-ICAM-2 represents a chimeric molecule
consisting of the extracellular domain of mouse E-cadherin and trans-
membrane/cytoplasmic domain of rat CD43, mouse CD44, or mouse
ICAM-2, respectively. The extracellular domain of E-cadherin was used
as an epitope tag to detect the cell surface expression of each chimeric
molecule in L fibroblasts expressing no detectable E-cadherin. Several
mutant proteins, E-43/1-31, E-44/1-19, E-44/20-70, and E-43/KRR:NGG,
were described in detail previously (Yonemura et al., 1998). To obtain
cDNA encoding VSVG-tagged ezrin (pSK/mEz-VSVG), an oligonucle-
otide encoding 11 COOH-terminal amino acids of VSVG was ligated into
the 3
 
9
 
 terminal end of mouse ezrin cDNA (Funayama et al., 1991) accord-
ing to Algrain et al. (1993). A cDNA fragment of pSK/mEz-VSVG was in-
serted into the HindIII-HpaI fragment of the p
 
b
 
act-CAT9 (Fregien and
Davidson, 1986) to construct its expression vector (pA/mEz-VSVG). Plas-
mids encoding ezrin mutants on the COOH-terminal threonine (T567)
were generated by PCR with appropriate primers from pSK/mEz-VSVG.
Alanine or aspartic acid was substituted for T567 (pA/mEz-T/A-VSVG or
pA/mEz-T/D-VSVG, respectively).
Cells were transfected with DNA using Lipofectin or Lipofectamine
(GIBCO BRL). Cultured cells on coverslips were washed twice with Opti-
MEM (GIBCO BRL), and incubated for 3–5 h with 1 ml Opti-MEM con-
taining 1 
 
m
 
g of plasmid DNAs and 10 
 
m
 
l of the reagents, followed by addi-
tion of 3 ml of normal medium containing FCS. Cells were then cultured
for 3–5 d. Since transfection with Lipofectin or Lipofectamine occasion-
ally caused damage to the cell surface structures of transfected cells, cells
were also transfected by microinjection using a set of manipulators (MN-
 
1. 
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188 and MO-189; Narishige) connected to an Eppendorf microinjector
5242 (Eppendorf, Inc.). Expression vectors in injection buffer (100 mM
KCl, 10 mM Hepes buffer, pH 7.5) were injected into the nuclei of cells
cultured on coverslips. Cells were examined 12–24 h after injection.
 
EGF Treatment of A431 Cells
 
Subconfluent A431 cells on coverslips in DME with 10% FCS were trans-
ferred to DMEM without FCS and cultured for 6–12 h. Recombinant hu-
man EGF (GIBCO BRL) was added at a final concentration of 100 ng/ml.
Cells were incubated for 30 s, and quickly fixed and processed for immu-
nofluorescence microscopy or SDS-PAGE followed by immunoblotting.
In some experiments, cells were microinjected with expression vectors, al-
lowed to express proteins for 6–18 h, serum-starved, treated with EGF,
and then processed for immunofluorescence microscopy.
 
Immunofluorescence Microscopy
 
L and CV-1 Cells. 
 
Cells were fixed with 1–4% fresh formaldehyde in 0.1 M
Hepes buffer (pH 7.5) for 15 min. After three washes with PBS containing
30 mM glycine (G-PBS), cells were soaked in blocking solution (G-PBS
containing 2% normal goat serum) for 5 min and incubated with anti–
E-cadherin mAb (ECCD-2) diluted with the blocking solution for 10 min.
Cells were then washed three times with G-PBS, treated with 0.2% Triton
X-100 in G-PBS for 10 min, and washed with G-PBS. Cells were then
soaked in blocking solution for 10 min, incubated with CR22 for 30 min,
washed three times with G-PBS, and incubated with secondary antibodies
for 30 min. DTAF-conjugated goat anti–rat IgG antibody (Chemicon) and
Cy3-conjugated goat anti–mouse IgG antibody (Amersham International)
were used as secondary antibodies. For triple labeling, FITC-phalloidin
(Molecular Probes, Inc.), Cy3-conjugated goat anti–rat IgG antibody
(Amersham International), and Cy5-conjugated goat anti–mouse IgG an-
tibody (Amersham International) were used. Cells were washed three
times, then mounted in 90% glycerol-PBS containing 0.1% para-phen-
ylenediamine and 1% 
 
n
 
-propylgalate. Specimens were observed using a
Zeiss Axiophot photomicroscope (Carl Zeiss) with appropriate combina-
tions of filters and mirrors. Photographs were taken on T-MAX 400 film
(Eastman Kodak Co.), or recorded with a cooled CCD camera (SenSys
0400, 768 
 
3
 
 512 pixels; Photometrics) controlled by a Power Macintosh
7600/132 and the software package IPLab Spectrum V3.1 (Signal Analyt-
ics Corp.).
 
MTD-1A Cells. 
 
Cells were fixed and doubly stained with anti–E-cad-
herin mAb (ECCD-2) and anti-ERM mAb (CR22) as described above.
Alternatively, cells were microinjected with expression vectors, washed
with cold culture medium the next day, and incubated with cold hy-
bridoma culture medium containing anti-CD44 mAb (IM7.8.1) and anti–
E-cadherin pAb for 15 min at 4
 
8
 
C. After washing twice with cold culture
medium, cells were fixed with 1% formaldehyde in 0.1 M Hepes buffer
(pH 7.5) for 15 min at room temperature. Cells were washed, permeabi-
lized, and soaked in blocking solution. Cy2-conjugated goat anti–rabbit
IgG antibody (Amersham International) and Cy3-conjugated goat anti–
rat IgG antibody were used as secondary antibodies.
 
A431 Cells. 
 
For double labeling of cells with 297S and TK88 to detect
CPERMs and total ERM proteins, respectively, cells were fixed with 10%
trichloroacetic acid for 15 min on ice (Hayashi et al., 1999). In this case,
TK89 which also detected all ERM proteins was not used, since the
epitope for 297S is overlapped with that for TK89. To label cells with
ECCD-2, TK89, P5D4, and/or FITC-phalloidin, they were fixed with 4%
formaldehyde in 0.1 M Hepes buffer (pH 7.5) for 15 min. Cells were
washed, permeabilized, and soaked in blocking solution. Cy2-conjugated
goat anti–rabbit IgG antibody, Cy2-conjugated donkey anti–mouse IgG
antibody (Jackson ImmunoResearch Laboratories, Inc.), Cy3-conjugated
goat anti–mouse IgG (Amersham), Cy3-conjugated goat anti–rat IgG an-
tibody, and/or Cy5-conjugated goat anti-mouse IgG antibody were used as
secondary antibodies. In A431 cells, cell surface expression of E-cadherin-
chimeric molecules was hard to detect because these cells express consid-
erable amounts of endogenous E-cadherin. However, E-cadherin-chi-
meric molecules could be detected by staining cells with ECCD-2 after
permeabilization with Triton X-100 because these molecules, but not en-
dogenous E-cadherin, were accumulated in the cytoplasm in large
amounts.
 
Immunoscanning Electron Microscopy
 
Polystyrene latex beads with a sulfate group on their surface (0.1 
 
m
 
m Fluo-
Spheres; Molecular Probes) were coated with avidin according to the
method of Molday et al. (1974). 1 d after microinjection with the expres-
sion vector encoding E-43, CV-1 cells on coverslips were fixed with 4%
formaldehyde in 0.1 M Hepes buffer (pH 7.5) for 20 min, washed with
G-PBS three times, soaked in blocking solution for 10 min, and then incu-
bated in blocking solution containing anti–E-cadherin mAb, ECCD-2 for
20 min. Cells were washed with G-PBS, incubated with biotinylated goat
anti–rat IgG antibody (Amersham International) in blocking solution,
and then washed with G-PBS. Samples were incubated with the avidin-
coated beads suspended in blocking solution for 1 h. Cells were washed
with G-PBS and fixed with 2.5% glutaraldehyde in 0.1 M Hepes buffer
(pH 7.5) for 2 h followed by postfixation with the same buffer containing
1% OsO
 
4
 
 at 4
 
8
 
C for 1 h. Samples were then washed with distilled water,
dehydrated through a graded series of ethanol, transferred into isoamyl
acetate, and dried in a critical point drier (Hitachi Co.) after substitution
with liquid CO
 
2
 
. Dried samples were coated with gold using a gold sputter
coater (Eiko Engineering), and were examined under a scanning electron
microscope (model S-800; Hitachi Co.).
 
Immunoblotting
 
Subconfluent A431 cells cultured on a 35-mm dish were serum-starved for
6 h as described above. With or without EGF treatment (100 ng/ml) for 30 s,
cells were washed with ice-cold PBS twice, and then recovered in 200 
 
m
 
l of
SDS-PAGE sample buffer by scraping. Proteins in 20 
 
m
 
l of the sample
were separated by SDS-PAGE and transferred onto nitrocellulose mem-
branes. Blots were first incubated with anti-phosphotyrosine mAb
(4G10), which were localized using the enhanced chemiluminescence
Western blotting detection system (Amersham). Bound antibodies were
then removed from the membranes by incubating with 7 M guanidine-
HCl, 50 
 
m
 
M EDTA, 20 mM 2-mercaptoethanol for 10 min at room tem-
perature. These membranes were incubated with anti-CPERM mAb
(297S) to detect threonine-phosphorylated ERM proteins, then bound
mAb was again removed. Finally, these membranes were incubated with
anti-ERM protein pAb (TK89) to total ERM proteins.
 
Results
 
Overexpression of ERMBMPs in Fibroblastic Cells
 
In our previous study, we transfected L cells with cDNAs
encoding several chimeric molecules containing the extra-
cellular domain of E-cadherin and the transmembrane/cy-
toplasmic domain of CD43, CD44, or ICAM-2 (E-43, E-44,
or E-ICAM-2, respectively), and showed that these chi-
meric molecules were concentrated in microvilli together
with ERM proteins (Yonemura et al., 1998). Then, we at-
tempted to examine the abilities of these chimeric mole-
cules to elongate microvilli using stable transfectants.
However, the microvillar elongation was not clearly ob-
served in these cells, probably because the stable transfec-
tants expressed relatively low levels of chimeric molecules.
Next, we examined the effects of transient overexpression
of these chimeric molecules on L cell surface morphology.
The expression and localization of each chimeric mole-
cule was detected with anti–E-cadherin mAb, ECCD-2,
which recognized the extracellular domain of E-cadherin,
and microvilli were specifically visualized by immunofluo-
rescence staining with anti-ERM protein mAb, CR22. As
shown in Fig. 1, a and b, when the expression level of E-43
was sufficiently high, expressed E-43 was not only colocal-
ized with ERM proteins in microvilli but also caused elon-
gation of microvilli, as compared to nontransfected L cells
(Fig. 1 g). The number of microvilli did not appear to in-
crease. Overexpression of E-44 or E-ICAM-2 gave the
same results (Fig. 1, c–f). Overexpression of E-43/1-31 (a
deletion mutant of E-43 lacking the COOH-terminal re-
gion but which carries the juxta-membrane ERM-binding
region of CD43 cytoplasmic domain; see Yonemura et al., 
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1998) also induced microvillar elongation (data not shown).
Immunofluorescence microscopy with ezrin-, radixin-, or
moesin-specific mAbs revealed that in all cases ezrin, ra-
dixin, and moesin were recruited to the elongated mi-
crovilli without any bias (data not shown).
Two distinct control experiments were performed. First,
wild-type E-cadherin was introduced into L cells. As pre-
viously reported (Yonemura et al., 1998), E-cadherin was
distributed diffusely over the cell surface (Fig. 2 a), and
the length and number of ERM-positive microvilli were
not changed (Fig. 2 b). Second, two chimeric molecules
lacking the ERM-binding ability were introduced into L
cells: E-44/20-70 in which the juxta-membrane ERM-bind-
ing region was deleted from the E-44 cytoplasmic domain
and E-43/KRR:NGG in which the juxta-membrane ERM-
binding region of E-43 was disrupted by site-directed mu-
tation (see Yonemura et al., 1998). These chimeric mole-
cules did not cause elongation of microvilli in transient
transfectants (Fig. 2, c–f).
Furthermore, the effects of overexpression of E-43 on
the cortical actin cytoskeleton organization were exam-
ined (Fig. 3). In the dorsal cortex of nontransfected L cells,
stress fibers and relatively short microvillar core actin bun-
dles were observed (arrow in Fig. 3 b). In the dorsal cortex
of E-43–expressing cells, stress fibers were disrupted with
concomitant formation of relatively long microvillar actin
bundles (asterisk in Fig. 3 b), whereas ventral stress fibers
were not affected (data not shown). In E-cadherin–over-
Figure 1. Microvillar elonga-
tion in L fibroblasts overex-
pressing ERMBMPs. L trans-
fectants transiently expressing
E-cadherin chimeric molecules
with the transmembrane/cyto-
plasmic domain of CD43 (E-43,
a and b), CD44 (E-44, c and d),
or ICAM-2 (E-ICAM-2, e and f)
were doubly stained with anti–
E-cadherin mAb (a, c, and e),
and anti-ERM mAb (b, d, and
f). In these cells, microvilli were
significantly elongated, where
both ERMBMPs and ERM pro-
teins were recruited (inset,
higher magnification). Cells
were transfected by microinjec-
tion. As a control, parental L
cells were stained with anti-
ERM mAb (g). Bar, a–g, 10 mm;
insets, 2.5 mm. 
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expressing cells, dorsal stress fibers were not affected
(data not shown).
Next, another fibroblastic cell line, CV-1, was used. CV-1
cells bear short microvilli and were used to examine the ef-
fects of villin on microvillar elongation (Friederich et al.,
1989). When E-43 was transiently introduced into CV-1
cells, microvillar elongation was more clearly demon-
strated than in L cells (Fig. 4). The length of microvilli was
then quantitatively compared between nontransfected and
E-43–expressing CV-1 cells using anti–ERM mAb-stained
images (Fig. 5). In nontransfected cells, microvilli were
mostly shorter than 1 
 
m
 
m (0.53 
 
6
 
 0.33 
 
m
 
m; 
 
n
 
 
 
5
 
 320),
whereas in E-43–expressing cells most microvilli were 3–4
 
m
 
m in length (3.5 
 
6
 
 1.4 
 
m
 
m; 
 
n
 
 
 
5
 
 300). These results are
comparable with those in villin-induced microvilli (2.4
 
m
 
m) (Friederich et al., 1989). Finally, the surface morphol-
ogy of these cells was examined by immunoscanning elec-
tron microscopy (Fig. 6). To detect cells transiently ex-
pressing E-43, the extracellular domain of E-cadherin was
detected with anti–E-cadherin mAb labeled with biotiny-
lated secondary antibody followed by avidin-conjugated
beads. The surface of nontransfected cells lacking bead la-
beling was characterized by numerous short microvilli
(Fig. 6 a). In contrast, many elongated microvilli were ob-
served on the surface of E-43–expressing cells together
with scattered beads (Fig. 6 b).
 
Overexpression of ERMBMPs in Epithelial Cells
 
When E-43 was introduced into cultured MTD-1A epithe-
lial cells, E-43 was concentrated at ERM-positive mi-
crovilli at their apical membrane surface, but did not in-
duce apparent elongation of microvilli (Fig. 7, a and b).
Instead, in these E-43–overexpressing cells, the endog-
enous microvillar integral membrane protein, CD44,
was significantly excluded from microvilli (Fig. 7, c and
d). Overexpression of E-44 also gave the same results,
whereas that of E-cadherin did not affect the microvillar
localization of endogenous CD44 (Fig. 7, e–h). This effect
appeared to be dependent on the level of E-43 or E-44 ex-
pression. In cultured fibroblastic L cells, E-43, E-44, or
E-ICAM-2 did not cause exclusion of endogenous CD44
from microvilli (data not shown).
Another epithelial cell line, A431, was examined. Simi-
lar to MTD-1A cells, overexpression of E-43 (Fig. 8, a and
b), E-44, or E-ICAM-2 (data not shown) did not induce
elongation of microvilli. In A431 cells, EGF treatment was
reported to induce morphological changes in the cell sur-
Figure 2. L fibroblasts overex-
pressing membrane proteins
lacking the ERM-binding abil-
ity. L transfectants transiently
expressing wild-type E-cad-
herin (E-cad, a and b), E-44/20-
70, a mutant E-44 lacking the
juxta-membrane ERM-binding
region (E-44/20-70, c and d), or
E-43/KRR:NGG, a mutant E-43
bearing site-directed disrupted
ERM-binding region (E-43/
KRR:NGG, e and f), were dou-
bly stained with anti–E-cadherin
mAb (a, c, and e) and anti-ERM
mAb (b, d, and f). No elongated
microvilli were observed. Cells
were transfected by microinjec-
tion (a, b, e, and f) or by lipofec-
tion (c and d). Bar, a–f, 10 mm;
insets, 2.5 mm. 
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face such as microvillar elongation and ruffling with
concomitant activation of ezrin (Chinkers et al., 1979;
Bretscher, 1989; Franck et al., 1993; Berryman et al.,
1995). Interestingly, as shown in Fig. 8, c and d, when
E-43–overexpressing cells were treated with EGF, within
30 s significantly longer microvilli appeared on the cell sur-
face as compared to surrounding nontransfected cells.
Ezrin was clearly recruited into and concentrated in these
overelongated microvilli. This type of EGF-dependent
overelongation of microvilli was not observed in A431
cells expressing E-43/KRR:NGG that has no binding abil-
ity to ERM proteins (Fig. 8, e and f).
 
ERM Proteins Phosphorylated at the COOH-terminal 
Threonine as Activated Forms
 
The difference in the effects of overexpression of ERM-
BMPs between fibroblastic and epithelial cells suggested
that in fibroblasts ERM proteins are more efficiently ac-
tivated than in epithelial cells (see Fig. 11). If this is the
case, it is likely that in A431 cells EGF effectively acti-
vates ERM proteins. ERM proteins phosphorylated at the
COOH-terminal threonine residue (T567, T564, and T558
in ezrin, radixin, and moesin, respectively) have been pro-
posed to function as active forms in cross-linking ERM-
BMPs to actin filaments (Nakamura et al., 1995; Matsui et
al., 1998; Oshiro et al., 1998; Pietromonaco et al., 1998;
Shaw et al., 1998; Simons et al., 1998; Hayashi et al., 1999).
Figure 3. Changes in cortical actin filament organization in L fi-
broblasts transiently overexpressing E-43. Cells were triply
stained with anti–E-cadherin mAb (E-43, a), FITC-phalloidin
(F-actin, b), and anti-ERM mAb (ERM, c). Nontransfected cells
(compare a with b) were characterized by dorsal stress fibers (ar-
row in b) and short microvilli (c), whereas in E-43–overexpress-
ing cells long microvillar core actin bundles were induced with
concomitant disruption of dorsal stress fibers (asterisk in b). The
precise colocalization of F-actin and ERM proteins in elongated
microvilli in E-43–expressing cells is shown at higher magnifica-
tion in the insets. Cells were transfected by microinjection. Bar,
a–c, 10 mm; insets, 2 mm.
Figure 4. Microvillar elongation in CV-1 fibroblasts transiently
overexpressing E-43. Cells were doubly stained with anti–E-cad-
herin mAb (E-43, a) and anti-ERM mAb (ERM, b). In E-43–
expressing CV-1 cells, microvilli were significantly elongated by
recruiting E-43 as well as ERM proteins as compared to sur-
rounding nontransfected cells (a and b). E-43 overexpression did
not appear to increase the density of microvilli. Microvillar elon-
gation was more clearly demonstrated at higher magnification
when nontransfected cells (c) and E-43–overexpressing cells (d)
were stained with anti-ERM mAb. Cells were transfected by mi-
croinjection. Bars, a and b, 10 mm; c and d, 5 mm. 
Yonemura et al. 
 
Microvillar Organization and ERM-binding Membrane Proteins
 
1503
 
We examined the effects of EGF on the threonine phos-
phorylation of ERM proteins in A431 cells (Fig. 9).
As reported previously (Hunter and Cooper, 1981;
Bretscher, 1989; Franck et al., 1993), immunoblotting of
EGF-treated A431 cells with anti-phosphotyrosine mAb
revealed that ezrin as well as EGF receptor were heavily
tyrosine-phosphorylated (Fig. 9 A, upper panel). In A431
cells with or without EGF treatment, anti-ERM pAb
(TK89) identified almost equal amounts of ezrin and
moesin, but only a trace amount of radixin (Fig. 9 A, lower
panel). Previously, we generated mAb 297S which specifi-
cally recognized CPERMs (Matsui et al., 1998). Immuno-
blotting with this mAb clearly revealed that the amount of
CPERMs was increased in A431 cells after EGF treatment
(Fig. 9 A, middle panel). Importantly, not only ezrin but
also moesin were phosphorylated at their COOH-terminal
threonine residues. MTD-1A cells and L cells contained
CPERMs in comparable amounts to EGF-treated A431
cells (Fig. 9 A).
We then compared the behavior of CPERMs with that
of total ERM proteins by immunofluorescence micros-
copy during the activation of ERM proteins induced
by EGF treatment (Fig. 9 B). Before EGF treatment,
CPERMs were hardly detected with some exceptional sig-
nals from the cell surface (Fig. 9 B, panel a). Total ERM
proteins were distributed diffusely in the cytoplasm and in
a punctate manner on the dorsal surface (Fig. 9 B, panel
b). When cells were treated with EGF for 30 s, the staining
intensity of CPERMs was increased markedly on cell sur-
face structures including elongating microvilli but not in
the cytoplasm (Fig. 9 B, panel c). In contrast, the total
ERM proteins were still detected in large amounts in the
cytoplasm in addition to the cell surface (Fig. 9 B, panel d).
These observations favored the suggestion that CPERMs
represent activated ERM proteins.
To further evaluate this suggestion experimentally, we
performed site-directed mutagenesis on ezrin which was
predominant among ERM proteins in A431 cells. The
COOH-terminally VSVG-tagged ezrin (Ez-VSVG) was
shown previously to behave similarly to endogenous ezrin
(Algrain et al., 1993; Crepaldi et al., 1997). Also, in serum-
starved A431 cells Ez-VSVG was codistributed with en-
dogenous ERM proteins (Fig. 10, a and b). When the
COOH-terminal threonine residue of ezrin (T567) was
mutated to alanine (Ez-T/A-VSVG; nonphosphorylatable
ezrin), the expressed mutant ezrin was again codistributed
with endogenous ezrin in the cytoplasm as well as on the
cell surface of serum-starved A431 cells (Fig. 10, c and d).
In sharp contrast, when T567 was mutated to aspartic acid
(Ez-T/D-VSVG), which was expected to mimic the T567-
phosphorylated form of ezrin, the expressed mutant was
preferably enriched at the cell surface to elongate mi-
crovilli in serum-starved A431 cells (Fig. 10 e). These
elongated microvilli contained actin filaments along their
length (Fig. 10, g and h), and the expressed Ez-T/D-VSVG
often formed large aggregates on the cell surface or in the
cytoplasm where actin filaments were recruited (arrows in
Fig. 10, g and h). In contrast, when Ez-T/D-VSVG was in-
troduced into L cells, no elongation of microvilli was de-
tected (data not shown).
 
Discussion
 
Although microvilli are ubiquitous membrane surface
structures, their physiological functions and the molecular
mechanism behind their organization have not been fully
elucidated. It has been reported that overexpression of
some cytoskeletal or lipid-binding proteins results in the
elongation of microvilli (Friederich et al., 1989; Arpin et al.,
1994b; Ma et al., 1997), but no information regarding the
involvement of integral membrane proteins in the mi-
crovillar organization is available. In this study, we first
showed that overexpression of several ERMBMPs such as
E-43, E-44, and E-ICAM-2 induced the elongation of mi-
crovilli in fibroblasts such as L and CV-1 cells. This activity
Figure 5. Length distribution of microvilli in E-43–expressing
(open box) and nontransfected (closed box) CV-1 cells. The
length of each microvillus was measured from anti-ERM mAb-
stained images (see Fig. 4 b). In nontransfected cells, microvilli
were relatively short (0.53 6 0.33 mm; n 5 320), whereas in E-43–
overexpressing cells they were significantly elongated (3.5 6 1.4 mm;
n 5 300). Cells were transfected by lipofection.
Figure 6. Scanning electron microscopic surface images of non-
transfected (a) and E-43–overexpressing (b) CV-1 cells. E-43–
expressing cells were identified by surface labeling by 0.1-mm
beads (arrows) which recognized the extracellular domain of
E-cadherin (see Materials and Methods in detail). Note the sig-
nificant difference in microvillar length between a and b. Cells
were transfected by microinjection. Bar, 1 mm. 
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of these integral membrane proteins was dependent on
their direct binding to ERM proteins, since the removal of
the ERM-binding domains from their cytoplasmic do-
mains resulted in loss of activity. Furthermore, as shown in
Fig. 3, this ERMBMP-dependent elongation of microvilli
was associated with disruption of the dorsal stress fibers,
suggesting that the expressed ERMBMPs recruited not
only ERM proteins but also actin filaments. Of course, the
possibility cannot be excluded that unidentified cytoplas-
mic proteins other than ERM proteins are also involved in
such integral membrane protein-induced microvillar orga-
nization in some types of cells. In human RPM-MC mela-
noma cells, CD44 mutants lacking the ezrin-binding do-
main were reported to still localize at microvilli together
with ezrin (Legg and Isacke, 1998), and in some types of
tissues CD44 and ERM proteins are not necessarily colo-
calized (Berryman et al., 1995; von Andrian et al., 1995;
Nakamura and Ozawa, 1996).
Interestingly, in epithelial cells such as MTD-1A and
A431 cells, these ERMBMPs did not induce the elonga-
tion of microvilli. Instead, they caused exclusion of endog-
enous CD44 from preexisting microvilli in MTD-1A cells.
This differential behavior of ERMBMPs in epithelial and
fibroblastic cells could be explained if the pool size of acti-
vated ERM proteins is larger in fibroblastic cells than in
epithelial cells. However, immunoblotting did not identify
any significant difference in the amount of CPERMs
(which may correspond to activated ERM proteins as dis-
Figure 7. Transient overexpres-
sion of E-43 or E-44 in MTD-1A
epithelial cells. Cells were dou-
bly stained with anti–E-cadherin
mAb (a) and anti-ERM mAb
(b) or with anti–E-cadherin pAb
(c, e, and g) and anti-CD44
mAb (d, f, and h). Overexpres-
sion of E-43 (a–d) or E-44 (e
and f) did not induce microvillar
elongation (a and b), but caused
exclusion of CD44 from preex-
isting microvilli (c–f). Overex-
pression of E-cadherin (g and h)
did not affect the distribution of
CD44. Cells were transfected by
microinjection. Bar, 10 mm. 
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cussed below) between fibroblastic L cells and epithelial
MTD-1A cells (Fig. 9 A). Thus, as shown schematically in
Fig. 11, A and B, we postulated that in epithelial cells used
in this study the ability to convert ERM proteins from in-
active form to active form was suppressed as compared to
fibroblastic cells. In response to increases in the amount of
ERMBMPs, ERM proteins in the cytoplasm of fibroblasts
would be efficiently activated with their concomitant re-
cruitment to organize microvilli. In contrast, since in epi-
thelial cells the activation of ERM proteins in response to
increases in the amount of ERMBMPs was suppressed,
the introduced ERMBMPs would compete out endoge-
nous CD44 from the membrane-bound activated ERM
proteins in preexisting microvilli. This interpretation was
Figure 8. Transient overexpres-
sion of E-43 or E-43/KRR:NGG
in A431 cells. Cells were doubly
stained with anti–E-cadherin
pAb (a and c)/anti-ezrin mAb,
M11 (b and d), or anti–E-cad-
herin mAb, ECCD-2 (e)/anti-
ERM pAb, TK89 (f) in the ab-
sence (a and b) or presence (c–f)
of EGF. In this experiment, cells
were stained with antibodies af-
ter Triton X-100 treatment, re-
sulting in intense cytoplasmic
staining with anti–E-cadherin (a,
c, and e). M11 did not bind to
ezrin in the cytoplasm strongly
(b and d). When cells were ex-
posed to EGF for 30 s, even in
nontransfected cells, short ezrin-
positive microvilli appeared on
the cell surface, but E-43–
expressing cells elongated sig-
nificantly longer ezrin-positive
microvilli (d). In sharp contrast,
cells expressing E-43/KRR:
NGG, which lacks the binding ability to ERM proteins, elongated short ERM-positive microvilli at the similar level to the surrounding
nontransfected cells (f) at 30 s after EGF treatment. Cells were transfected by microinjection. Bar, 10 mm.
Figure 9. Phosphorylation of
the COOH-terminal threonine
of ERM proteins in EGF-
treated A431 cells. (A) Serum-
starved A431 cells were incu-
bated with EGF for 30 s, then
immediately they were applied
onto SDS-PAGE followed by
immunoblotting with anti-phos-
photyrosine mAb (4G10) (up-
per panel, P-Y), a mAb (297S)
specific for CPERM (middle
panel, CP-ERM), or anti-ERM
pAb (TK89) (lower panel,
ERM). The same nitrocellulose
membrane was repeatedly
probed with each antibody, con-
firming that ezrin and moesin
were predominant in A431 cells,
that ezrin but not moesin was ty-
rosine-phosphorylated, and that
both ezrin and moesin were
phosphorylated at the COOH-terminal threonine residue. Similar immunoblotting was performed also in MTD-1A cells and L cells.
EGF-R, EGF receptor; E, ezrin; R, radixin; M, moesin. Bars indicate molecular masses of 200, 116, 97, 66, 45, 31, and 21 kD from the
top, respectively. (B) Immunofluorescence images of serum-starved A431 cells doubly stained with mAb 297S specific for CPERM (a
and c) and TK88 specific for all ERM proteins (b and d) before (a and b) and 30 s after (c and d) EGF treatment. CPERM appeared in
large amounts at microvilli and cell–cell borders only in EGF-treated cells (c). Some amount of total ERM proteins appeared to be
translocated from the cytoplasm to microvilli after EGF treatment (c and d). Bar, 10 mm. 
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supported by the observations in EGF-treated A431 cells
(Fig. 11, C–E). Bretscher and colleagues reported that
EGF treatment increased the levels of tyrosine phos-
phorylation and oligomerization of ezrin in A431 cells, re-
sulting in the elongation of microvilli and membrane ruf-
fles by recruiting ezrin (Bretscher, 1989; Berryman et al.,
1995). These findings suggest that in these cells, EGF di-
rectly or indirectly released the suppression of the ezrin
(and probably ERM protein) activation process (Fig. 11
C). The present results indicated that in these EGF-
treated A431 cells, in which ERM proteins could be effi-
ciently activated in response to increases in the amount of
ERMBMPs, the overexpression of E-43 caused marked
elongation of microvilli (Fig. 11, D and E). Furthermore,
introduction of Ez-T/D-VSVG, which mimicked activated
ERM proteins, into serum-starved A431 cells but not L
cells induced microvillar elongation. These findings sug-
gest that in L cells the elongation of microvilli is regulated
by the amount of ERMBMPs, whereas in serum-starved
A431 cells it is regulated by the activation of ERM pro-
teins as shown in Fig. 11. Based on these observations, we
concluded that ERMBMPs such as CD43, CD44, and
ICAM-2 can serve as organizing centers for microvilli in
collaboration with activated ERM proteins. Of course,
the role of ERMBMPs remains undetermined in the
normal organization of microvilli in a variety of cells be-
cause our conclusion resulted from overexpression ex-
periments. In support of our model, lymphocytes from
Figure 10. Localization of site-
directed mutants of ezrin in se-
rum-starved A431 cells. VSVG-
tagged ezrin (Ez-VSVG) (a and
b), Ez-VSVG mutant which
T567 was mutated to alanine
(Ez-T/A-VSVG) (c and d), or
Ez-VSVG mutant which T567
was mutated to aspartic acid
(Ez-T/D-VSVG) (e–h) was
transfected to A431 cells by mi-
croinjection. Cells were doubly
stained with anti-VSVG mAb
(P5D4) (a, c, and e)/anti-ERM
pAb (TK89) (b, d, and f), or
anti-VSVG mAb (P5D4) (g)/
FITC-phalloidin (h). Ez-VSVG
and Ez-T/A-VSVG did not af-
fect cell morphology and were
codistributed with endogenous
ERM proteins diffusely in the
cytoplasm as well as on the cell
surface (a–d). In contrast, Ez-T/
D-VSVG induced microvillar
elongation and was localized
exclusively at the cell surface
structures such as microvilli
(e and f). Actin filaments were
recruited to Ez-T/D-VSVG–
positive elongated microvilli
throughout their length (inset, g
and h). Occasionally, on the cell
surface or intracellular vesicles
overexpressed Ez-T/D-VSVG
formed large aggregates that re-
cruited actin filaments (arrows
in g and h). Bar, 10 mm; insets,
2.5 mm. 
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patients with Wiskott-Aldrich syndrome, where CD43 is
defective, were relatively devoid of microvilli (Kenney et al.,
1986).
The question has naturally arisen as to the nature of the
activated state of ERM proteins and how they are acti-
vated. Ezrin has been reported to be tyrosine-, serine-, and
also threonine-phosphorylated in vivo. Ezrin is heavily ty-
rosine-phosphorylated in response to EGF in A431 and to
hepatocyte growth factor in LLC-PK1 cells (Gould et al.,
1986; Bretscher, 1989; Berryman et al., 1995; Crepaldi et
al., 1997). However, tyrosine phosphorylation of ezrin did
not alter the association of ezrin with the cytoskeleton
(Gould et al., 1986; Egerton et al., 1992). Furthermore,
even when two tyrosine residues in ezrin that are known to
be major phosphorylation sites by EGF receptor (Krieg
and Hunter, 1992) were mutated to phenylalanine, trans-
fected LLC-PK1 cells became unresponsive to hepatocyte
growth factor in terms of cell motility and tubulogenesis,
but the localization of ezrin at microvilli was not affected
(Crepaldi et al., 1997). These findings suggest that tyrosine
phosphorylation of ezrin (and probably ERM proteins) is
not required for ezrin activation as a membrane-cytoskele-
ton linker.
Several lines of evidence suggest that serine/threonine
phosphorylation of ERM proteins is associated with their
activation (Urushidani et al., 1989; Hanzel et al., 1991;
Chen et al., 1995; Kondo et al., 1997; Oshiro et al., 1998;
Shaw et al., 1998). Moesin was reported to be threonine-
phosphorylated at its COOH terminus during thrombin
activation in platelets (Nakamura et al., 1995). Phosphor-
ylation at the COOH-terminal threonine residue was
shown to affect the direct interaction between the NH
 
2
 
-
and COOH-terminal halves of radixin in vitro (Matsui
et al., 1998), suggesting that this phosphorylation keeps
ERM proteins in an opened (activated) form. The results
of our previous investigations and of the present study in-
dicated that CPERMs represent the activated ERM pro-
teins shown in Fig. 11. Immunofluorescence microscopy
with a mAb specific for CPERMs showed that they were
highly concentrated at microvilli of cultured fibroblasts
(Hayashi et al., 1999) and also at elongated microvilli of
L and CV-1 cells overexpressing ERMBMPs (data not
shown). When A431 cells were treated with EGF, levels of
CPERMs were shown to be increased by immunoblotting,
which were concentrated in elongating microvilli on the
cell surface (Fig. 9), although it remains unclear how the
activation of EGF receptor tyrosine kinase resulted in
the phosphorylation of COOH-terminal threonine of ERM
proteins. As expected, CPERMs were also highly concen-
trated at overelongated microvilli in EGF-treated A431
cells overexpressing ERMBMPs (data not shown). Fur-
thermore, transfection experiments with site-directed mu-
tants of ezrin revealed that Ez-T/D-VSVG (which mim-
icked CPERMs) was preferably recruited to the plasma
membranes of serum-starved A431 cells to elongate mi-
crovilli. Similar results with mutated moesin were recently
reported in COS7 cells (Oshiro et al., 1998). In contrast,
Ez-T/A-VSVG, a nonphosphorylatable form at the COOH-
terminal threonine, was codistributed with endogenous
ERM proteins at the cytoplasm as well as plasma mem-
branes (Fig. 10). Since ERM proteins form dimers or oli-
gomers (Berryman et al., 1995; Bretscher et al., 1995), the
localization of Ez-T/A-VSVG, i.e., inactivated form of
ERM protein, on plasma membranes can be explained if
these mutant molecules are incorporated into oligomers of
endogenous ERM proteins.
Figure 11. Possible involvement of ERMBMPs and activated
ERM proteins in organizing microvilli. (A) Fibroblastic cells such
as L cells and CV-1 cells bear short microvilli on their surface. In
this model, ERM proteins were effectively activated in response
to increases in amounts of ERMBMP in these cells. Overex-
pressed ERMBMPs such as E-43, E-44, and E-ICAM-2 then re-
cruit these activated ERM proteins and actin filaments to elon-
gate microvilli. (B) Epithelial cells such as MTD-1A cells bear
short microvilli on their surface. The activation process of ERM
proteins is postulated to be suppressed in these cells. Due to the
limited amount of activated ERM proteins, overexpressed ERM-
BMPs do not elongate microvilli but compete out endogenous
CD44 from preexisting microvilli. (C) A431 cells carry only very
short microvilli in the absence of EGF. The activation process of
ERM proteins is also postulated to be suppressed in these epithe-
lial cells. EGF treatment released this suppression mechanism,
resulting in an increase in the amount of activated ERM proteins,
which are recruited to the cytoplasmic domain of endogenous
ERMBMPs to elongate microvilli. (D) Even when E-43 is over-
expressed in A431 cells in the absence of EGF, microvilli are not
elongated due to the suppression of the activation process of
ERM proteins. (E) When E-43 is overexpressed in A431 cells in
the presence of EGF, increased amounts of activated ERM pro-
teins are recruited to the overexpressed E-43 to cause overelon-
gation of microvilli. 
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Current knowledge regarding how ERM proteins are
activated, i.e., how the COOH-terminal threonine resi-
dues of ERM proteins are phosphorylated in vivo, is still
limited. Rho-associated kinase and/or protein kinase C-
 
u
 
are good candidates for the kinase responsible for produc-
tion of CPERMs in vivo (Matsui et al., 1998; Oshiro et al.,
1998; Pietromonaco et al., 1998). Although protein kinase
C-
 
u
 
 but not Rho-associated kinase was shown in vitro to
phosphorylate full-length ezrin and moesin to directly
open the closed form of ERM proteins (Simons et al.,
1998), further analyses would be required to determine
conclusively which serine/threonine kinase by itself func-
tions as an activator for ERM proteins in vivo. Phospho-
inositides such as phosphatidylinositol 4,5-bisphosphate
were also thought to be key factors in opening of the
closed ERM proteins (Niggli et al., 1995; Hirao et al.,
1996). Further detailed analyses of how ERM proteins are
activated in response to increases in amounts of ERM-
BMPs in fibroblasts and how this activation process is
suppressed in epithelial cells will lead to a better under-
standing of the molecular mechanism of cell surface mor-
phogenesis including the formation and destruction of
microvilli in general.
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